tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Revenue

Compare
16 Followers

Prescient Therapeutics Limited Revenue

Prescient Therapeutics Limited had a revenue of 3.11M in the quarter ending Jun 30, 2025, with 149.04%. This bring the company's revenue in the last twelve months to 4.36M, Decreased 44.19%. In the fiscal year ending Dec 31, 2025, Prescient Therapeutics Limited had annual revenue of 4.36M with 17.36% growth.
Revenue (ttm)
4.36M
Revenue Growth
P/S Ratio
24.14
Revenue/Employee
AU$1,452,132
Employees
3
Market Cap
AU$105.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
4.36M644.40K+117.36%
Dec 31, 2024
3.71M1.28M+152.88%
Dec 31, 2023
2.43M539.00K+128.53%
Dec 31, 2022
1.89M704.00K+159.41%
Dec 31, 2021
1.19M156.00K+115.16%
Dec 31, 2020
1.03M-619.00K+62.44%
Dec 31, 2019
1.65M708.23K+175.36%
Dec 31, 2018
939.77K-284.47K+76.76%
Dec 31, 2017
1.22M221.74K+122.12%
Dec 31, 2016
1.00M